Innate Immunity
Journal metrics
Annual Clarivate and SCImago indicators.
| Year | JCR | SJR | ||||
|---|---|---|---|---|---|---|
| IF | IF quartile | Rank (percentile) | SJR | SJR quartile | Rank (percentile) | |
| 2025 | 3.5 | Q2 | 57.6% | 0.926 | Q2 | 81.8% |
| 2024 | 2.8 | Q2 | 51.3% | 0.917 | Q2 | 81.9% |
| 2023 | 2.8 | Q3 | 49.6% | 0.760 | Q2 | 78.2% |
| 2022 | 3.2 | Q3 | 48.8% | 0.657 | Q2 | 74.8% |
| 2021 | 3.0 | Q3 | 40.0% | 0.644 | Q2 | 75.0% |
| 2020 | — | — | 0.921 | Q2 | 83.4% | |
| 2019 | — | — | 0.910 | Q2 | 83.5% | |
| 2018 | — | — | 0.884 | Q2 | 81.2% | |
Impact history
Annual SJR and Impact Factor trend.
SJRIF
Journal record
eISSN
1753-4267
ISSN
1753-4259
country
GBcoverage
1996-1997, 1999, 2008-2026